J Vet Sci.  2004 Dec;5(4):309-318.

General pharmacological profiles of bee venom and its water soluble fractions in rodent models

Affiliations
  • 1Department of Veterinary Physiology, College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National University, Seoul 151-742, Korea. JHL1101@snu.ac.kr
  • 2Department of Pharmacology, College of Medicine, Chonbuk National University, Jeonju 561-756, Korea.
  • 3Hormone Research Center, College of Veterinary Medicine, Chonnam National University, Gwangju 500-757, Korea.
  • 4Department of Acupuncture & Moxibustion, College of Oriental Medicine, Kyung Hee University, Seoul 130-701, Korea.
  • 5Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, St Paul, MN, 55108, USA.

Abstract

Recently, the antinociceptive and anti-inflammatory efficacy of bee venom (BV, Apis mellifera) has been confirmed in rodent models of inflammation and arthritis. Interestingly, the antinociceptive and anti-inflammatory effect of whole BV can be reproduced by two water-soluble fractions of BV (>20 kDa:BVAF1 and<10 kDa: BVAF3). Based on these scientific findings, BV and its effective water-soluble fractions have been proposed as potential anti-inflammatory and antinociceptive pharmaceuticals. While BV's anti-inflammatory and antinociceptive properties have been well documented, there have been no careful studies of potential, side effects of BV and its fractions when administered in the therapeutic range (BV, 5 microgram/kg; BVAF1, 0.2 microgram/kg: BVAF3, 3 microgram/kg; subcutaneous or intradermal). Such information is critical for future clinical use of BV in humans. Because of this paucity of information, the present study was designed to determine the general pharmacological/physiological effects of BV and its fractions administration on the rodent central nervous, cardiovascular, respiratory and gastrointestinal system. Subcutaneous BV and its fractions treatment did not produce any significant effects on general physiological functions at the highest dose tested (200-fold and 100-fold doses higher than that used clinically, respectively) except writhing test. These results demonstrate that doses of BV or BV subfractions in the therapeutic range or higher can be used as safe antinociceptive and anti-inflammatory agents.

Keyword

bee venom; general pharmacology; antinociception; anti-inflammation

MeSH Terms

Analgesics/*pharmacology
Animals
Anti-Inflammatory Agents/*pharmacology
Bee Venoms/*pharmacology
Cardiovascular System/*drug effects
Central Nervous System/*drug effects
Digestive System/*drug effects
Male
Mice
Mice, Inbred ICR
Rabbits
Rats
Rats, Sprague-Dawley
Respiratory System/*drug effects
Full Text Links
  • JVS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr